Neurochemists explore the chemical processes that occur in the brain, focusing on how neurotransmitters, hormones, and other chemicals influence brain function and behavior. They investigate how these chemicals are synthesized, released, and regulated within the nervous system, examining their roles in mood regulation, cognition, and motor control. Neurochemistry plays a critical role in understanding disorders such as depression, anxiety, schizophrenia, and Parkinson's disease, all of which involve imbalances in brain chemistry. Neurochemists also study how drugs, both therapeutic and recreational, affect the brain’s chemical environment and contribute to neurological and psychiatric conditions. Their research provides valuable insights into developing more effective medications, targeting specific neurotransmitter systems to treat conditions like epilepsy, bipolar disorder, and addiction. Furthermore, neurochemists study the molecular mechanisms of neurodegenerative diseases, such as Alzheimer's, where protein misfolding and deposition contribute to cognitive decline. Their work in neurochemical signaling and receptor function has significant implications for drug development, as they aim to create more selective, personalized treatments with fewer side effects. Additionally, neurochemists are involved in studying the impact of diet and lifestyle on brain chemistry, which can influence brain aging, cognitive decline, and overall mental health.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States